KAT2B and hepatocellular carcinoma: The P300/CBP-associated factor (PCAF), which is a well-known HAT, was expressed at low level in HCC, and has been proven to inhibit HCC tumorigenesis both in vitro and in vivo (Zheng et al., 2013).